Planned Parenthood Votes Statement on Mifepristone Supreme Court Ruling
For Immediate Release: June 13, 2024
WASHINGTON, D.C. — Today, in response to the Supreme Court’s ruling in Food and Drug Administration v. Alliance for Hippocratic Medicine — which leaves unchanged FDA’s approval of and access to mifepristone, a safe and effective drug used in medication abortion — Jenny Lawson, executive director of Planned Parenthood Votes, released the statement below. This attack on medication abortion could continue, as the case will be sent back down to the federal district court, which has already allowed Kansas, Missouri, and Idaho to intervene in the case.
“Today, the Supreme Court did the bare minimum. It rejected a baseless attack on mifepristone by a group of anti-abortion physicians. But it sent this case back down to the same federal district court that tried to restrict mifepristone in the first place, which could allow this case to continue.
“But let’s be clear: We would not be here if it weren't for Donald Trump. Donald Trump has proudly claimed responsibility for overturning Roe, and called it “a beautiful thing” as state after state bans abortion, he’s tried to defund Planned Parenthood, and he’s said that abortion patients should be punished. He paved the way for the current abortion access crisis and is responsible for every abortion ban and every patient who is suffering. This crisis fueled by Donald Trump does not improve with today’s ruling. That’s why Planned Parenthood Votes is working to defeat him and his anti-abortion allies this November.”
###
Planned Parenthood Votes is an independent expenditure political committee registered with the Federal Election Commission.
Paid for by Planned Parenthood Votes, 123 William St, NY NY 10038. Not authorized by any candidate or candidate’s committee. |